Subscribe to RSS
DOI: 10.1055/s-0029-1238319
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York
A Polymorphism within the Fructosamine-3-kinase Gene is Associated with HbA1c Levels and the Onset of Type 2 Diabetes Mellitus
Publication History
received 20.05.2009
first decision 16.07.2009
accepted 17.08.2009
Publication Date:
15 October 2009 (online)

Abstract
Background: Non-enzymatic glycation is a process, which leads to the formation of advanced glycation endproducts. These compounds are involved in the development of diabetic microvascular complications. Fructosamine-3-kinase (FN3K) is an intracellular enzyme that phosphorylates fructosamines resulting in fructosamine-3-phosphate, which subsequently decomposes to inorganic phosphate, 3-deoxyglucasone and the unmodified amine. Recently, the G900C (rs1056534) single nucleotide polymorpism (SNP) of the FN3K gene was found to be associated with the enzyme activity.
Objective/Design: The aim of the study was to investigate the impact of the SNP on clinical and biochemical features and microvascular complications of type 2 diabetes.
Patients: A total of 859 type 2 diabetic subjects and 265 healthy controls were enrolled in the study and were genotyped with PCR-RFLP method.
Results: Genotype frequencies were as follows, CC: 5%, GC: 54%, GG: 41% in subjects with type 2 diabetes and CC: 6%, GC: 51%, GG: 43% in the controls. Diabetic subjects with the CC variant had lower HbA1c levels compared with the others (CC: 6.48±0.05%; GC: 7.66±0.09%; GG: 7.68±0.09%; p<0.001). Furthermore, in case of the CC allelic variant type 2 diabetes was diagnosed at a later age than in case of GC or GG variants (CC: 56.0±1.90 years; GC: 52.0±0.62 years; GG: 50.1±0.71 years; p<0.05). Logistic regression analysis did not reveal association between CC genotype and diabetic complications, such as diabetic nephropathy, neuropathy and retinopathy (OR=1.036, CI 95% 0.652–1.647, p=0.880; OR=0.985, CI 95% 0.564–1.721 p=0.958; OR=1.213, CI 95% 0.470–3.132, p=0.690, respectively).
Conclusion: We conclude that the G900C polymorphism associates with the level of HbA1c and the onset of the disease, but not with either of the diabetic microvascular complications.
Key words
fructosamine-3-kinase - single nucleotide polymorphism - HbA1c - diabetic microvascular complication
References
- 1
Conner JR, Beisswenger PJ, Szwergold BS.
The expression of the genes for fructosamine-3-kinase and fructosamine-3-kinase-related
protein appears to be constitutive and unaffected by environmental signals.
Biochem Biophys Res Commun.
2004;
323
932-936
MissingFormLabel
- 2
Delpierre G, Collard F, Fortpied J. et al .
Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human
erythrocytes.
Biochem J.
2002;
365
801-808
MissingFormLabel
- 3
Delpierre G, Veiga-da-Cunha M, Vertommen D. et al .
Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with
polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites.
Diabetes Metab.
2006;
32
31-39
MissingFormLabel
- 4
Delpierre G, Vertommen D, Communi D. et al .
Identification of fructosamine residues deglycated by fructosamine-3-kinase in human
hemoglobin.
J Biol Chem.
2004;
279
27613-27620
MissingFormLabel
- 5
Jeppsson JO, Kobold U, Barr J. et al .
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Approved
IFCC reference method for the measurement of HbA1c in human blood.
Clin Chem Lab Med.
2002;
40
78-89
MissingFormLabel
- 6
Schmitt S, Linder M, Ständker L. et al .
Identification of CML-modified proteins in hemofiltrate of diabetic patients by proteome
analysis.
Exp Clin Endocrinol Diabetes.
2008;
116
26-34
MissingFormLabel
- 7
Stratmann B, Tschoepe D.
Sweet heart – contributions of metabolism in the development of heart failure in diabetes
mellitus.
Exp Clin Endocrinol Diabetes.
2008;
116
((Sl))
S40-S45
MissingFormLabel
- 8
Szwergold BS, Howell S, Beisswenger PJ.
Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and
evidence of activity in vivo.
Diabetes.
2001;
50
2139-2147
MissingFormLabel
- 9
Veiga da-Cunha M, Jacquemin P, Delpierre G. et al .
Increased protein glycation in fructosamine 3-kinase-deficient mice.
Biochem J.
2006;
399
257-264
MissingFormLabel
- 10
Vlassara H, Bucala R, Striker L.
Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical
implications for diabetes and aging.
Lab Invest.
1994;
70
138-151
MissingFormLabel
- 11
Zietz B, Buechler C, Kobuch K. et al .
Serum levels of adiponectin are associated with diabetic retinopathy and with adiponectin
gene mutations in Caucasian patients with diabetes mellitus type 2.
Exp Clin Endocrinol Diabetes.
2008;
116
532-536
MissingFormLabel
Correspondence
Prof. I. WittmannMD, PhD
2nd Department of Medicine and Nephrological Center Faculty of Medicine University
of Pécs
H-7624 Pécs
Pacsirta u. 1.
Hungary
Phone: +36-72-536-050
Fax: +36-72-536-051
Email: istvan.wittmann@aok.pte.hu